The Biocidal Products Committee (BPC) discussed three applications for the approval of an active substance. The BPC concluded that the following active substance should not be approved: carbendazim for product-type 9 (fibre, leather, rubber and polymerised materials preservatives). The committee's opinion is that carbendazim, which meets the exclusion criteria, cannot be approved for product-type 9 because of unacceptable risks posed to the environment that cannot be mitigated. Regarding the approval of two other active substances, the BPC requested the respective evaluating Member States to assess whether the active substances meet the new criteria for endocrine-disrupting properties before the committee adopts its opinions.
展开▼
